1. Home
  2. CVAC vs HIFS Comparison

CVAC vs HIFS Comparison

Compare CVAC & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • HIFS
  • Stock Information
  • Founded
  • CVAC 2000
  • HIFS 1834
  • Country
  • CVAC Germany
  • HIFS United States
  • Employees
  • CVAC N/A
  • HIFS N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • HIFS Major Banks
  • Sector
  • CVAC Health Care
  • HIFS Finance
  • Exchange
  • CVAC Nasdaq
  • HIFS Nasdaq
  • Market Cap
  • CVAC 637.1M
  • HIFS 603.3M
  • IPO Year
  • CVAC 2020
  • HIFS N/A
  • Fundamental
  • Price
  • CVAC $2.95
  • HIFS $270.14
  • Analyst Decision
  • CVAC Hold
  • HIFS
  • Analyst Count
  • CVAC 3
  • HIFS 0
  • Target Price
  • CVAC $10.00
  • HIFS N/A
  • AVG Volume (30 Days)
  • CVAC 523.1K
  • HIFS 10.5K
  • Earning Date
  • CVAC 11-12-2024
  • HIFS 01-17-2025
  • Dividend Yield
  • CVAC N/A
  • HIFS 0.92%
  • EPS Growth
  • CVAC N/A
  • HIFS N/A
  • EPS
  • CVAC N/A
  • HIFS 10.55
  • Revenue
  • CVAC $70,565,734.00
  • HIFS $58,408,000.00
  • Revenue This Year
  • CVAC $738.59
  • HIFS N/A
  • Revenue Next Year
  • CVAC N/A
  • HIFS N/A
  • P/E Ratio
  • CVAC N/A
  • HIFS $25.93
  • Revenue Growth
  • CVAC 75.11
  • HIFS N/A
  • 52 Week Low
  • CVAC $2.22
  • HIFS $150.11
  • 52 Week High
  • CVAC $5.28
  • HIFS $300.00
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 49.55
  • HIFS 44.87
  • Support Level
  • CVAC $3.17
  • HIFS $273.30
  • Resistance Level
  • CVAC $3.56
  • HIFS $286.00
  • Average True Range (ATR)
  • CVAC 0.18
  • HIFS 6.52
  • MACD
  • CVAC 0.01
  • HIFS -1.91
  • Stochastic Oscillator
  • CVAC 24.69
  • HIFS 14.04

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About HIFS Hingham Institution for Savings

Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.

Share on Social Networks: